Trial Condition(s):
Safety and Pharmacokinetics of Azelaic Acid Foam, 15% in Papulopustular Rosacea
15386
Not Available
Not Available
Assessment of pharmacokinetics of Azelaic Acid Foam after repeated skin application and in comparison to Azelaic Acid gel.
Assessment of safety after repeated skin application.
- diagnosis of moderate papulopustular rosacea - free of any clinically significant disease
- body weight less than 50 or more than 130 kg - clinically significant disease which could interfere with the study
Locations | |
---|---|
Locations Novum Pharmaceutical Research Services of Nevada Inc. Las Vegas, United States, 89121 | Contact Us: E-mail: [email protected] Phone: Not Available |
Investigator-blinded, Randomized, Cross-over, Multiple Dose Phase I Study on Safety and Pharmacokinetics of Topically Applied Azelaic Acid Foam, 15% Compared to Azelaic Acid Gel, 15% in Subjects With Papulopustular Rosacea
Trial Type:
Interventional
Intervention Type:
Drug
Trial Purpose:
Treatment
Allocation:
Randomized
Blinding:
Single Blind
Assignment:
Crossover Assignment
Trial Arms:
2